Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Chao Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7023-3577; OpenAlex author ID A5005509944. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2018: 5 papers · 2019: 3 papers · 2020: 2 papers

Papers 10

  1. HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. Co-author DOI 10.1093/abbs/gmz169↗
  2. Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-08301-3↗
  3. Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.01.013↗
  4. Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes. Co-author DOI 10.1097/mpa.0000000000001338↗
  5. The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer. Co-author DOI 10.2147/cmar.s211363↗
  6. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00262-018-2235-8↗
  7. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer. First author DOI 10.1016/j.canlet.2018.01.017↗
  8. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer. Co-author DOI 10.1016/j.pan.2018.08.003↗
  9. Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001073↗
  10. Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions. First author DOI 10.1186/s13045-017-0551-7↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianjun Yu · 10 shared papers, 2018–2020 · strength 0.84
  2. Chen Liu · 10 shared papers, 2018–2020 · strength 0.84
  3. Guopei Luo · 10 shared papers, 2018–2020 · strength 0.84
  4. Kaizhou Jin · 10 shared papers, 2018–2020 · strength 0.84
  5. Zhiyao Fan · 9 shared papers, 2018–2020 · strength 0.76
  6. He Cheng · 8 shared papers, 2018–2020 · strength 0.67
  7. Kun Fan · 6 shared papers, 2018–2020 · strength 0.50
  8. Yitao Gong · 4 shared papers, 2019–2020 · strength 0.39
  9. Quanxing Ni · 4 shared papers, 2018–2019 · strength 0.32
  10. Yiyin Zhang · 3 shared papers, 2018 · strength 0.22
  11. Yunzhen Qian · 2 shared papers, 2020 · strength 0.20
  12. Jin Xu · 2 shared papers, 2018–2019 · strength 0.16
  13. Meng Guo · 2 shared papers, 2018 · strength 0.14
  14. Jiang Long · 2 shared papers, 2018 · strength 0.14
  15. Xu He · 1 shared paper, 2020 · strength 0.10
  16. Cheng He · 1 shared paper, 2018 · strength 0.07
  17. Andrew Louis Warshaw · 1 shared paper, 2018 · strength 0.07
  18. Kun Fan · 1 shared paper, 2018 · strength 0.07
  19. Liang Liu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.